Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

Immunogenicity of Del19 EGFR mutations in Chinese patients affected by lung adenocarcinoma

Abstract Background Mutant peptides presented by cancer cells are superior vaccine candidates than self peptides. The efficacy of mutant K-Ras, P53 and EGFR (Epidermal Growth Factor Receptor) peptides have been tested as cancer vaccines in pancreatic, colorectal, and lung cancers. The immunogenicity...

Full description

Bibliographic Details
Main Authors: Deng Pan, Dapeng Zhou, Weijing Cai, Weibo Wu, Wen Ling Tan, Caicun Zhou, Yanyan Lou
Format: Article
Language:English
Published: BMC 2019-11-01
Series:BMC Immunology
Subjects:
Lung cancer
Neo-antigen
INDEL
Immunotherapy
PD1 checkpoint blocking antibody
Online Access:http://link.springer.com/article/10.1186/s12865-019-0320-1

Internet

http://link.springer.com/article/10.1186/s12865-019-0320-1

Similar Items